Future paradigms for precision oncology
Open Access
- 19 May 2016
- journal article
- case report
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (29) , 46813-46831
Abstract
Future paradigms for precision oncologyKeywords
This publication has 82 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trialTargeted Oncology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromesBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006
- The Hallmarks of CancerCell, 2000